ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

ACHV Achieve Life Sciences Inc

4.59
0.015 (0.33%)
Last Updated: 10:57:49
Delayed by 15 minutes

Period:

Draw Mode:

Volume 20,126
Bid Price 4.60
Ask Price 4.62
News -
Day High 4.64

Low
3.03

52 Week Range

High
10.30

Day Low 4.48
Company Name Stock Ticker Symbol Market Type
Achieve Life Sciences Inc ACHV NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.015 0.33% 4.59 10:57:49
Open Price Low Price High Price Close Price Prev Close
4.57 4.48 4.64 4.575
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
289 20,126 $ 4.57 $ 91,994 - 3.03 - 10.30
Last Trade Time Type Quantity Stock Price Currency
11:01:50 2 $ 4.6001 USD

Achieve Life Sciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
98.21M 21.17M - 0 -29.82M -1.41 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Achieve Life Sciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ACHV Message Board. Create One! See More Posts on ACHV Message Board See More Message Board Posts

Historical ACHV Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week4.554.664.354.4951,3680.040.88%
1 Month4.644.69934.024.4866,399-0.05-1.08%
3 Months4.915.003.824.4397,912-0.32-6.52%
6 Months3.995.983.034.1890,2310.6015.04%
1 Year7.9310.303.035.2194,009-3.34-42.12%
3 Years10.9711.752.006.2998,614-6.38-58.16%
5 Years4.0023.240.2257442.11523,0700.5914.75%

Achieve Life Sciences Description

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the global smoking health epidemic through the development and commercialization of cytisinicline.

Your Recent History

Delayed Upgrade Clock